Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 29, 2025
Children’s Charity With Beyoncé’s Dad as Ambassador of Hope Celebrates New Children’s Book Release About Beating Cancer
Time4Sharing.org launches children’s book on resilience and hope, reflecting its 25-year mission to support kids facing illness and adversity. ORLANDO, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- Time4Sharing.org, the global children’s …
SABER College anuncia fechas de inicio para los programas de Asistente Médico, Enfermería Profesional y ESOL en línea
La institución mantiene su misión de educación centrada en el estudiante, ofreciendo orientación, apoyo profesional y caminos accesibles al éxito desde 1992. MIAMI, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- SABER College, institución …
SABER College Announces Fall 2025 Start Dates for Medical Assisting, Professional Nursing, and Online ESOL Programs
SABER College continues its mission of student-centered education, offering guidance, career support, and accessible pathways to success. MIAMI, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- SABER College, an established leader in …
Industry Spotlight: Revival Research Institute Will Be at the SCRS Global Site Solutions Summit 2025
ORLANDO, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- Revival Research Institute, LLC is heading to Orlando, Florida for the SCRS Global Site Solutions Summit, September 28 – October 1, 2025. This four-day event is one of the few times …
Senior Crossroads of Florida Named 2025 Best of Florida Award Winner For Excellence in Elder Care
LAKEWOOD RANCH, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- Senior Crossroads of Florida, Inc. has been named a 2025 Best of Florida Award winner, a distinction that highlights the company’s dedication to providing comprehensive care …
New Quality Improvement Program Provides Enhanced Education in the Care of Patients with Disabilities
CLEARWATER, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- IntellectAbility®, a leading healthcare software and education company dedicated to improving health outcomes for people with intellectual and developmental disabilities (IDD), is …
Artelo Biosciences Announces Proposed Underwritten Public Offering
SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-1 63% (26/41) disease control rate (“DCR”) and 37% (15/41) objective response rate (“ORR”) in evaluable …
NANOBIOTIX annonce de nouveaux résultats de Phase 1 qui continuent de confirmer le potentiel de JNJ-1900 (NBTXR3), avec un anti-PD-1, en tant que potentielle nouvelle option thérapeutique de première ou deuxième ligne ou plus dans le CETEC R/M naïf ou …
Le traitement continue de présenter un profil de tolérance favorable avec une faisabilité d’injection confirmée chez les 103 patients lourdement prétraités atteints de CETEC R/M naïfs ou résistants aux anti-PD-1. Chez les patients naïfs aux anti-PD-1 …
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
Not for dissemination in the United States of America VANCOUVER, British Columbia, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited …
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
SARASOTA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation …
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
– Extends cash runway into at least mid-2027 – SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug …
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. Patients in Cohort 9 experienced the largest improvements in tissue …
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fiscal Q2 2027 BURLINGTON, Mass., Sept. 29, 2025 (GLOBE …
MAIA Biotechnology Announces $2.25 Million Private Placement
CHICAGO, IL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into …
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET Company introduces fiscal year 2026 Revenue and Adjusted EBITDA guidance Company appoints new Chief Operating Officer GARDNER, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Precision Optics …
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
PONTE VEDRA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced that it will participate …
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
Designed to unlock potential value by creating two independent, publicly traded companies with different business objectives and opportunities Upon completion, the royalty management company will manage royalties and milestone payments from financial …
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will host a virtual investor event on ANB033, its CD122 …